June 29, 2021 -- Boston Children's Hospital and cell and gene therapy accelerator ElevateBio have inked a five-year collaboration to develop cell and gene therapies for patients.
Under the deal, Boston Children's and ElevateBio will form multiple cell and gene therapy companies together and provide Boston Children's researchers access to the company's technologies, manufacturing, and expertise, according to the institution. What's more, the researchers will also be guaranteed dedicated viral vector manufacturing space at ElevateBio's BaseCamp research and development manufacturing center.
In addition, ElevateBio will commit to sponsored research agreements with Boston Children's investigators as part of the company formation process, the hospital said.
Copyright © 2021 scienceboard.net